FDA Grants Emergency Use Authorization for NIH-Funded Over the Counter COVID-19 Home Test
FDA Grants Emergency Use Authorization for NIH-Funded Over the Counter COVID-19 Home Test
Last week, the Food and Drug Administration (FDA) granted emergency use authorization (EUA) for the first time for an at-home COVID-19 test that consumers will be able to buy over the counter. The test was developed with support from the National Institutes of Health’s (NIH’s) Rapid Acceleration of Diagnostics (RADx) Initiative, a program that aims to speed the development, commercialization, and implementation of technologies for COVID-19 testing.
Ellume USA LLC out of Valencia, California is the company that designed the test using a $30 million contract and technical support from the RADx initiative. The test will retail for around $30 and Ellume plans to distribute millions of home tests each month starting in 2021. The design incorporates real-time result sharing capabilities, so that health professionals, employers, and schools can efficiently track COVID-19 test results.
RADx is managed by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIH. ASME has been supportive of the mission of the NIBIB since its inception in 2001. NIBIB’s mission is to improve health by leading the development and accelerating the application of biomedical technologies. The Institute is committed to integrating the physical and engineering sciences with the life sciences to advance basic research and medical care.
For more information on ASME’s government relations agenda in the area of bioengineering, please read our “Investing in Bioengineering: Securing America’s Leadership Role in a 21st Century” position statement.
Ellume USA LLC out of Valencia, California is the company that designed the test using a $30 million contract and technical support from the RADx initiative. The test will retail for around $30 and Ellume plans to distribute millions of home tests each month starting in 2021. The design incorporates real-time result sharing capabilities, so that health professionals, employers, and schools can efficiently track COVID-19 test results.
RADx is managed by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) at NIH. ASME has been supportive of the mission of the NIBIB since its inception in 2001. NIBIB’s mission is to improve health by leading the development and accelerating the application of biomedical technologies. The Institute is committed to integrating the physical and engineering sciences with the life sciences to advance basic research and medical care.
For more information on ASME’s government relations agenda in the area of bioengineering, please read our “Investing in Bioengineering: Securing America’s Leadership Role in a 21st Century” position statement.
Related Content
5 Feedstocks for Biomass Energy Production
Apr 25, 2024
Wood, corn, even dung can heat homes and power industry. Discover energy from biomass.
The Evolving Manner of Leadership Skills
Mar 7, 2024
Good leaders must be flexible enough to know how changing times and circumstances affect their role in managing people and teams. But some situations still can benefit from an old-skill approach.
Infographic: Rounding the Peak on Carbon Emissions
Jan 18, 2024
Nearly 78 percent of the decrease in emissions is accounted for by the electric power sector, but auto efficiency also helped.
Energy Blog: Mirage or Oasis for Climate Action?
Dec 14, 2023
A wealthy petrostate might seem like an odd place to hold a major conference on climate action, but the positive results of COP28 show the importance of getting oil-rich nations onboard with carbon emissions reductions.